Following is a summary of current health news briefs. Structure's experimental obesity pill shows no signs of liver injury Structure Therapeutics said on Friday its experimental GLP-1 obesity pill did
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)